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A B S T R A C T
Background: Effective administration of tuberculosis therapy remains challenging. The recommended strategy of
direct observed therapy is challenging and its implementation has been limited in many settings. Digital ad-
herence technologies could be promising patient-centered strategies for monitoring adherence. However, few
quality studies have assessed patients’ experiences with these technologies.
Objective: To explore TB patients’ perceptions of a digital adherence intervention composed of a digital ad-
herence monitor and SMS texts.
Methods: We purposively sampled TB patients who owned phones, had been taking TB medication for at least a
month, and were receiving their treatment from Mbarara Regional Referral Hospital. We interviewed 35 TB pa-
tients to elicit information on perceptions of the proposed intervention which electronically monitors how they
take their medication, and sends SMS reminders to patients to help them take their medications, as well as send
SMS notifications to patients’ social supporters to provide the patient with assistance if possible. We inductively
analyzed data using content analysis to derive categories describing how participants perceived the intervention.
Results: Participants anticipated that the intervention would enhance medication adherence by reminding them
to take medication, and helping in the management of complicated regimen. Participants felt that monitoring
adherence could enable them to demonstrate their commitment to adherence. Participants expressed concerns
about not seeing the SMS on time and unintended TB status disclosure.
Conclusion: Digital adherence technologies may provide acceptable alternative approaches to monitoring TB
medication, especially in settings where DOT is difficult to implement.
1. Background
Poor TB (tuberculosis) medication adherence contributes to treatment
failure, development of drug-resistant TB, and secondary transmission
[1–3]. Enabling effective administration of TB therapy remains challenging
[4]. The directly observed therapy (DOT) strategy recommended by the
World Health Organization requires that patients take their medication
under the supervision of a health worker or a trained treatment supporter to
ensure that patients adhere to treatment. However, DOT does not perform
better than self-administered therapy for diseases relapse and acquired drug
resistance [5]. Moreover, this approach demands a significant time com-
mitment from health workers and treatment supporters, generates
substantial financial burdens, and inhibits patient autonomy [6,7]. For these
reasons, its implementation has been limited in many settings. For instance,
a Chinese study by Lei and colleagues found that only 14% of patients were
on DOT, of which 28% were lost to follow-up [8]. Alternative, innovative
approaches for effective administration of TB therapy are needed.
The WHO End TB Strategy 2017 suggests a suite of new interven-
tions to improve adherence, including mobile phone-based short mes-
sage service (SMS) text messages, digital medication monitors that re-
cord when a pill container is opened, and “supportive treatment
supervision by treatment partners” [9]. In addition to supporting
treatment supervision, the monitors can motivate adherence and be
used to deliver interventions such as alarms or SMS [10]. Given
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widespread telephone ownership and mobile network coverage in sub-
Saharan Africa [11], SMS can provide affordable means of commu-
nicating with TB patients about their medication adherence. A recent
study from Uganda indicates that most TB patients (75%) own mobile
phones and are willing to received TB-related communication via SMS
texts [12]. The same study indicates that even patients without mobile
phones were willing to receive SMS on a family phone.
Real-time versions of the digital medication monitors transmit records
of device openings via a cellular network. Such devices provide real-time
adherence information, enabling timely interventions to poor medication
adherers before consequences of non-adherence can develop. Real-time
adherence monitoring technologies with SMS reminders have been shown
to improve adherence to HIV antiretroviral therapy [13,14]. However,
high quality studies about the application of these technologies for TB
medication adherence are limited, especially in resource-limited settings.
Given the novelty of real-time adherence monitoring and SMS tech-
nologies for TB medication, an in-depth assessment of their potential
benefits and challenges is needed to inform the development of interven-
tions that can effectively meet the needs of prospective users. In this study,
we explored how TB patients perceive a real-time adherence monitoring
intervention consisting of (1) use of a real-time adherence monitoring de-
vice, and (2) SMS text messages providing adherence reminders to patients
and notifications to their social supporters (i.e., friends or family who have
helped them with medication or other needs previously).
2. Methods
2.1. Study design and setting
This study combines semi-structured interviews and surveys in a par-
allel mixed methods study design. TB patients were recruited from the TB
clinic within Mbarara Regional Referral Hospital (MRRH) in rural,
southwestern Uganda. Uganda ranks among the 22 countries with the
highest number of TB cases in the world, with the 16th position in 2016
[15]. The treatment completion rate stands at 75% in Uganda. The MRRH
TB unit provides care to approximately 600 TB patients annually. Newly
diagnosed patients receive free TB medication and counseling on the
benefits of TB medication. All patients with presumed drug-sensitive TB
self-administer their medications based on fixed dose combinations. The
clinic does not employ the DOT strategy due to the significant burdens it
places on patients and healthcare providers. Rather, TB patients are given
pills every 2 weeks for the first 2 months. After 2 months, the patients
return to the clinic to check for sputum conversion. Patients then collect
pills every month for an additional 4 months, with another conversion
check at 4 months and a final checkup at 6 months of treatment, which
can be extended up to 8 months to account for missed visits.
2.2. Selection of study participants
Between June 2017 and June 2018, authors AMT and WT purposively
sampled patients receiving TB treatment from Mbarara Regional Referral
Hospital. We aimed to achieve relatively balanced representation by
gender and HIV status to elicit diverse perspectives. Inclusion criteria were
as follows: (a) had chart documentation of drug-sensitive TB, (b) had ac-
cess to a mobile phone, (c) had been undergoing a first-line 6-month
course of anti-TB therapy as described above for at least 1 month, (d) were
18 years and older, (e) lived in Mbarara District, (f) were willing and able
to give consent, and (g) were willing and able to name one social sup-
porter. Adherence was not a consideration in participant selection.
2.3. The intervention technology: real-time adherence monitor (Wisepill
device)
The proposed intervention is composed of electronic device that
monitors how patients take their medication, and sends SMS reminders
to patients to help them take their medications, as well as sending SMS
notifications to patients’ social supporters to provide the patient with
assistance if possible. The SMS application is then linked to the real-time
adherence monitoring system. The contents of SMS reminders and noti-
fications are determined by each participant. The proposed default
message is “This is your reminder.” The SMS reminders are meant to
remind TB patients take their medication on time. For the first 3 months,
the intervention sends daily SMS notifications to social supporters irre-
spective of whether the patients take their medication. For the next 3
months, we send notifications only if the patient misses or delays taking
medication. As described in [24], the real-time adherence monitor
(Fig. 1) (Wisepill Technologies, Cape Town, South Africa), is a medica-
tion container that can hold up to 28 tablets of a 4-drug combination of
rifampicin, isoniazid, pyrazinamide, and ethambutol). When an in-
dividual opens it to take pills, the device records a date-and-time stamp.
An internal modem and SIM card enable the device to send a real-time
mobile signal to a secure web-sever (hosted in South Africa) by General
Packet Radio Service (GPRS). Receipt of this signal is taken as a proxy for
taking medication. GPRS maintains the data in transit until acknowl-
edgement of receipt by the web-server, which minimizes possible data
loss because of power failure or/and lack of internet connectivity. Data
transmission is backed up by the SMS to mitigate possible temporal GPRS
network disconnections. In the event of inadequate mobile network
coverage, the monitor stores openings in flash memory and sends them
when the network becomes available. The monitor also transmits a daily
‘heart beat’ that indicates current battery life, remaining airtime balance,
and signal strength as indication of its functionality. The monitor can be
charged using electricity or a solar device. Its battery life is 6 months.
2.4. Study procedures
Before the interview, we first oriented each participant about the
potential interventions to support adherence to TB medication. First, we
explained and demonstrated how the real-time adherence monitor
(Wisepill device) works, including how it monitors medication and sends
signals to researchers or health workers every time it is opened, how to
open it to insert/retrieve tablets, and how to close it after taking tablets.
Participants were then given the monitor and asked to explain what it
does and to practically demonstrate how it works to the researcher. We
then explained to participants how the intervention could send scheduled
(e.g., daily reminders) or triggered (i.e., a reminder triggered by a de-
layed/missed dose) SMS reminders to TB patients to help them take their
medications, as well as send SMS notifications to patients’ social sup-
porters to provide the patient with assistance if possible.
2.5. Data collection
Authors WT and AMT carried out separate semi-structured, in-depth
interviews with TB patients; both authors are bilingual in English and the
local language (Runyankole) and trained in qualitative research and re-
search ethics. Interviews were conducted in a private space at a research
office near the MRRH. Each interview lasted between 30 and 60 min. All
Fig. 1. The Wisepill device.
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questions in the interview guide were translated into the local language
(Runyankole) and back-translated to English by a different translator,
after which the two versions were compared for accuracy. Interviews
were conducted in the local language, digitally recorded, transcribed,
and translated to English. We elicited participants’ perceptions and opi-
nions about the different components of the integrated intervention, in-
cluding the real-time monitoring device, SMS reminders for patients, and
SMS notifications for social supporters. We solicited information about
how participants would feel about being monitored or sent an SMS text
about their TB medication, anticipated benefits of the intervention, and
anticipated challenges related to it. Following each interview, author
AM, with support from JEH and JLD, reviewed transcripts for quality,
clarity, and detail. WT and AMT also administered surveys eliciting in-
formation about participants’ preferences of the proposed intervention.
We also administered surveys to patients and social supporters to collect
information on socio-demographics, socio economic status, food security,
HIV status, cellular phone ownership and utilization, TB medication use,
and SMS text preferences.
2.6. Analysis
We used inductive content analysis [16] to derive categories de-
scribing and summarizing how participants perceived the intervention.
Initially, AM, WT, and ATM reviewed and discussed 20% of transcripts
for content relevant to participants’ perceptions about the intervention,
anticipated benefits, and challenges. AM and WT then assembled a
codebook from the identified concepts, using an iterative process,
which included developing codes to represent content, writing opera-
tional definitions, and selecting illustrative quotes. JEH, JLD, and DB
also reviewed and discussed the codebook. Following completion of the
codebook, AM and WT applied codes using NVIVO 11. Differences in
coding were harmonized through discussion. ATM and TW used STATA
13 to describe study participants and their preferences regarding fre-
quency and type of SMS texts.
2.7. Ethical reviews
All participants provided signed informed consent before study
participation. The Institutional Review Committee of Mbarara
University of Science and Technology, the Uganda National Council for
Science and Technology, and the Partners Human Research Committee
at Massachusetts General Hospital approved this study.
3. Results
3.1. Participant characteristics
Of 53 screened TB patients, 18 (34%) were excluded. Patients were
excluded for (individuals could have >1 criterion): having no cellphone
(n= 6; 11.3%), inability to use SMS text messages (n= 5; 9.4%), un-
willingness or inability to name at least one social supporter (n= 3;
5.7%), being <18 years old (n= 2; 3.8%), receiving a diagnosis of drug-
resistant TB (n= 1; 1.9%), and/or inability to provide informed consent
(n= 1; 1.9%). A total of 35 TB patients, of whom 15 (42.8%) were
persons living with HIV/AIDS, enrolled in the study between February
2017 and April 2018 (Appendix 1, Table A1). The majority of TB patients
were males (n= 20; 57.5%) in their early 30 s while the majority of
social supporters were females (n= 9; 60.0%) in their early 40 s. Only
one patient reported not being able to read Runyankole (local language),
while the majority of patients were able to read English (n= 27; 77.1%).
3.2. Survey results
The majority of patients (n= 27; 77.1%) reported that they some-
times delayed taking their medication, while 9 (25.7%) missed taking
medication sometimes (Appendix 2, Table A2). The main reason
participants cited for delaying medication was forgetfulness (n= 24;
68.6%). The majority of TB patients who were living with HIV (n= 12;
80%) reported forgetting to medication on time. Being mainly quali-
tative study, we did not see any obvious differences based on how long
patients had spent on medication. Most patients reported ever using
their phones for health-related purposes (n= 32; 91.4%); the most
frequently reported purpose being arranging transport to the clinic
(n= 23; 65.7%). Participants chose “phone not charged” (n= 26;
74.3%) and “someone else had my phone” (n= 25; 71.4%) as the most
common reasons they did not receive SMS immediately. Most partici-
pants (n= 24; 68.6%) preferred daily SMS reminders to weekly re-
minders. Participants preferred reminders to take medication (n= 30;
85.7%) to reminders to pick up medication at the clinic (n= 5; 14.3%).
3.3. Interview results
Participants said they thought the intervention would motivate
medication adherence by reminding them to take pills, which could
help them form new habits of adherence. Respondents who were living
with HIV noted that the reminders might also help them manage their
complicated regimen.
Participants felt that the technology could enable them to demon-
strate their commitment to following treatment instructions in order
not to disappoint researchers. Finally, participants felt the functionality
of the intervention may be limited if they did not see the SMS on time,
or if there were concerns about unintended TB status disclosure.
3.4. Reminding medication adherence
TB patients felt that SMS could serve as medication reminders to
overcome forgetfulness. SMS reminders, especially those that are sent
daily, were seen as an opportunity to familiarize oneself with medica-
tion adherence, especially among those who did not have experience
taking medication regularly.
“SMS reminders will help me get used to taking my medication. In
case I forget taking medication and I receive a SMS reminder I will
automatically remember.”
∼Male, 50 years, TB patient
Patients noted that taking medication after being reminded by the
SMS could develop a habit of taking the pills daily as prescribed. This
function was particularly important for patients with busy schedules
who can easily forget taking medication:
“Like sometimes I can forget especially when I am fixed with other
things. But when you send me an SMS, I can remember and im-
mediately take my medicine.”
∼ Male, 36 years, TB patient
Some TB patients had already developed their own informal version
of the intervention. They reported that they had previously received
reminders to take TB medication through mobile phone calls and SMS
texts from their social supporters to remind them take medication:
R: Sometimes my good friend calls me or sends me a text message on
my phone to remind me take my medicine. I work with him, but
when I am off duty, I think he gets worried that I might forget, so he
calls me or sends me a text to remind me take my medicine.
∼ Male, 27 years, TB patient
In particular, patients living with HIV reported that it was easy to
forget to take medication on time due to the number of drugs involved.
These patients noted that the complexity of their medication coupled
with the incurable nature of HIV could make adherence challenging.
Because I am taking very many drugs of HIV and TB drugs, so it is
good to be reminded to take my medication. Otherwise I can easily
forget, yet, I have so many thoughts especially about HIV which I am
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sure has no cure.
∼ Female, 47 years, TB/HIV patient
For these patients, reminders could cut through the complexity of
their drug regimen and emotional state to ensure adherence.
3.5. Demonstrating commitment to adherence
TB patients said that monitoring could provide an opportunity to
demonstrate their commitment to adherence by providing evidence of
their seriousness in following instructions. Patients perceived not taking
medication on time as a disappointment to people who gave them de-
vices, whom they believed cared about their health. To demonstrate
commitment to the health providers who will have invested in patients
by dispensing the devices, patients said they felt obliged to return that
care by “not letting that person down.”
“When I have the device, I know that I must take my medicine so
that people that gave it to me will not think that I am not serious in
following the instructions”.
∼ Male 37 years, TB patient
Some patients suggested that a sense of being especially cared for
might motivate them to work harder to adhere.
“If someone cares for you and gives you the device to help you take
your medication well and have good health, you should not let that
person down by not doing what he wants.”
∼ Male, 30 years, TB patient
TB patients described how the real-time monitor would “put them on
pressure” to take medication by monitoring and reporting their ad-
herence to perceived authority figures, thus motivating them to adhere.
This motivation stemmed from a desire not to disappoint their health-
care providers and be in ‘their bad books’.
The device will put me on pressure not to forget taking my medi-
cation so that that doctors can know that I take my medication on
time. Since you said that they will be seeing how I take my medi-
cation through the device, I will be serious because I know that
doctors want me to be well, and I don't want to be in their bad
books.
∼ Male, 27 years, TB Patient
Patients perceived this “pressure” positively because they associated
it with the healthcare workers’ desire for patients to be cured.
As further illustrated below, patients reported two concerns asso-
ciated with the use of digital adherence technologies.
3.6. Concerns: not seeing the SMS on time
TB patients anticipated technical limitations that could result in not
seeing the SMS reminders on time. Participants shared concerns about
phone sharing, depleted batteries, phone dysfunction, or inadequate
network coverage preventing them from seeing an SMS reminder im-
mediately. Some worried they would miss notifications while sleeping
or busy with work. Participants were concerned about the possibility of
not seeing the messages in time, which could limit the feasibility of the
intervention.
“If you send an SMS reminder when she has taken my phone, I will
definitely miss the reminder, which is a bad thing.”
∼ Female, 37 years, TB/HIV patient
3.7. Concerns: unintended TB status disclosure
Some patients were concerned about the possibility of unintentional
disclosure of their disease status. They worried that if SMS messages
specifically mentioned TB, if phones were shared, if unauthorized phone
access occurred, or if others recognized the Wisepill device, their TB status
would be known. TB patients living with HIV appeared more concerned
about disclosure compared to those without HIV. These patients feared
that unwanted disclosure could result in double stigma and discrimination.
Sometimes my phone is with my child or any other person so if the
SMS directly tells me to take my TB medication, the person may end
up knowing that I have TB. People see TB disease as a disease of the
unfortunate ones, and automatically associate TB with AIDS. So
there is that double stigma that follows you wherever you go, and of
course that makes me feel bad.
∼ Female, 38 years HIV/TB patient
4. Discussion
In this study, TB patients reported that a real-time adherence
monitor (Wisepill device), and SMS reminders could support medica-
tion adherence by reminding patients to take their medicine, which
could result into forming a habit of medication adherence. The re-
minders could also help TB patients living with HIV to manage the
complexities of having to adhere to multiple medications (known as
polypharmacy) since being reminded to take TB medication can also
indirectly remind a patient to take antiretroviral drugs. Monitoring
adherence could motivate patients to take their drugs in order not to
disappoint those that care for them. However, patients also worried
about the possibility of unintended TB status disclosure if others saw
the SMS message or monitor. They also expressed concerns about
missing reminders due to technical problems.
Real-time adherence monitoring interventions may remind patients
take their TB medication on time. In our study, patients described for-
getfulness as a major barrier to adherence, especially for those with busy
schedules, complex drug regimens, or inexperience with regular medica-
tion. Daily SMS reminders were preferred to weekly reminders in ad-
dressing forgetfulness due the possibility of facilitating a habit of medi-
cation adherence since they are aligned to the daily routine of taking
medication. Preference of daily SMS reminders has previously been re-
ported in an antiretroviral adherence study in the same setting [21].
However, it remains unknown whether TB patients would maintain the
preference of daily SMS reminders for the entire duration of their treat-
ment since there could be a possibility of patients being overwhelmed by
the messages; this issue is being explored in our current ongoing study.
Although the application of SMS reminders in supporting TB med-
ication adherence is still rare, there is some evidence that they could
improve TB medication adherence. For example, in a randomized trial
in China, audio reminders from a medication monitor improved TB
medication adherence with or without scheduled SMS reminders, while
scheduled SMS text alone did not [17]. Additionally, a recent study in
Pakistan showed no significant difference between the daily SMS arm
and control arm (no SMS) for treatment outcomes among patients with
drug-sensitive tuberculosis [18]. The potential of SMS texts to improve
TB medication adherence through a reminding function was also re-
ported in Peru [19], and in Uganda among TB patients living with HIV
[20]. Reminders have previously been linked to improved medication
adherence in other infectious and stigmatized diseases such as HIV/
AIDS in the same setting [13].
Participants associated real-time monitoring of pill-taking behaviors
and receiving SMS texts with feelings of being cared for and connected
to their healthcare providers. This connection could address the chal-
lenge of social isolation that frequently accompanies stigmatized dis-
eases. Feeling cared for and connected to the clinic can create a sense of
obligation to adhere. TB patients thought that electronic medication
monitoring would motivate them to take medication on time in order to
demonstrate their commitment to adherence to an audience of clinic
workers and/or social supporters. Real-time monitoring has previously
been associated with demonstrating commitment with regard to anti-
retroviral treatment among people living with HIV/AIDS in Uganda
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[21]. Adherence behaviors developed while using the electronic
monitor could potentially be maintained even after withdrawing the
technology [22]. The motivation to adhere also comes from self-per-
ceived need for patients to prove to social supporters that they are not
undermining supports’ efforts to help them regain their health. Social
supporters expect patients to adhere to their medications, and patients
comply to this expectation to maintain the inflow of support [23].
In our study, participants expressed concerns about missing SMS re-
minders. Ensuring personal phone ownership, providing solar-powered
phone chargers, and sending reminders at the participants’ pre-identified
time of preference could address some of the identified potential lim-
itations to receiving reminders. Although participants only reported po-
tential concerns associated with SMS reminders, in one of our previous
studies that employed a similar intervention among HIV patients, tech-
nical limitations that could potentially limit the functionality of the real-
time time monitor were identified [24]. These include difficulties in
charging the battery, absence of battery levels, inability of the monitor to
function without being charged, and opening the monitor without taking
medication or using the monitor for other medications. Teaching patients
to charge the device and informing them about the need to only use the
monitor for the intended medication, and to open it only when taking
medication could address some of these challenges.
The reported uunintended disclosure can interfere with patients’
privacy. This can result in stigma/discrimination and negative attitudes
that may limit access to support, limit coping strategies [25], and dis-
tress the patients. Emphasizing personal phone ownership, using mes-
sages that cannot easily be associated with TB/HIV, and/or using
password protected phones could mitigate this concern.
The main strength of this study is that it used a mixed-methods
approach to collect both closed- and open-ended data. In addition,
because the study was conducted in a rural sub-Saharan African area
and population, it has implications for similar settings. This study also
identifies important insights from TB patients that can inform the de-
velopment of monitoring technologies. This study is limited by the fact
that we asked participants about perceptions before they could use the
intervention in real life. Although we practically demonstrated the use
of the intervention to all participants, participants were not able to
describe actual experiences using the device or medication-related SMS
messages as part of their daily routine. Lastly, findings could be vul-
nerable to social desirability bias because participants self-reported
their preferences and anticipated uses of the monitoring intervention.
In sum, real-time adherence interventions could potentially provide
acceptable and feasible approaches to remind and motivate patients to
take medication regularly. They provide a promising alternative or
complementary approach to administering TB medication in settings
where DOT is difficult to implement. As real-time monitoring tech-
nology proliferates, understanding how these technologies are per-
ceived by prospective users is critical to developing interventions that
are acceptable, feasible and effective in improving TB medication ad-
herence. Findings from this formative study will inform the design of an
intervention to be implemented in an upcoming randomized, controlled
trial where a real-time monitoring intervention will be assessed for
acceptability, feasibility, and impact on TB medication adherence in
Uganda. Further research is needed to understand how participants in
diverse settings perceive this intervention.
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Female 15 (42.9%) 9 (60.0%)




Able to read English 27 (77.1%) 10 (66.7%)
Able to read Runyankole 34 (97.1%) 14 (93.3%)
Had regular income 18 (51.4%) 8 (53.3%)
Worried about food security 20 (57.1%) 8 (53.3%)
Living with HIV 15 (42.9%) 1 (6.7%)
Mean (SD) months of treatment
completed at time of interview
3.3 (1.49) –
SD = standard deviation.
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Table A2
Survey results for TB medication use, cellular phone ownership and utilization, and intervention preferences.
TB patients (n= 35)
TB medication use *
Often take pills at exact prescribed time 23 (65.7%)
Sometimes have delays 27 (77.1%)
Sometimes miss taking pills 9 (25.7%)
Reasons for delaying/missing medication*
Forgets 24 (68.6%)
Delayed somewhere 8 (22.9%)
Lacked food/drinks to take before taking medication 3 (8.6%)
Lacked transport to pick medication 1 (2.9%)
Cell phone utilization*
Ever used phone for health-related reason 32 (91.4%)
Check SMS 1–3 times a week 4 (11.4%)
Check SMS 4–6 times a week 4 (11.4%)
Check SMS >6 times a week 27 (77.3%)
Health-related reason for using a cell phone*
Arranging transport to clinic to pick medication 23 (65.7%)
Inquiring about TB medication 20 (57.1%)
Calling for money for basic needs 6 (17.1%)
Informing others about TB status 1 (2.9%)
Reasons for being delayed from usual schedule of receiving SMSa
Phone not charged 26 (74.3%)
Someone else had my phone 25 (71.4%)
Phone not functioning 15 (42.9)
Inadequate cellular network 16 (45.7%)
Preferred frequency of SMS reminders
Daily 24 (68.6%)
Weekly 11 (31.4%)
Preferred type of SMS reminder
Reminders for taking medication 30 (85.7%)
Reminders for picking pills from the clinic 5 (14.3%)
a Responses are not mutually exclusive.
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